Skip to main content
Top
Published in: World Journal of Surgery 5/2018

Open Access 01-05-2018 | Original Scientific Report

Growth of Focal Nodular Hyperplasia is Not a Reason for Surgical Intervention, but Patients Should be Referred to a Tertiary Referral Centre

Authors: Mirelle E. E. Bröker, Anne J. Klompenhouwer, Marcia P. Gaspersz, Annick M. E. Alleleyn, Roy S. Dwarkasing, Indra C. Pieters, Robert A. de Man, Jan N. M. IJzermans

Published in: World Journal of Surgery | Issue 5/2018

Login to get access

Abstract

Background

When a liver lesion diagnosed as focal nodular hyperplasia (FNH) increases in size, it may cause doubt about the initial diagnosis. In many cases, additional investigations will follow to exclude hepatocellular adenoma or malignancy. This retrospective cohort study addresses the implications of growth of FNH for clinical management.

Methods

We included patients diagnosed with FNH based on ≥2 imaging modalities between 2002 and 2015. Characteristics of patients with growing FNH with sequential imaging in a 6-month interval were compared to non-growing FNH.

Results

Growth was reported in 19/162 (12%) patients, ranging from 21 to 200%. Resection was performed in 4/19 growing FNHs; histological examination confirmed FNH in all patients. In all 15 conservatively treated patients, additional imaging confirmed FNH diagnosis. No adverse outcomes were reported. No differences were found in characteristics and presentation of patients with growing or non-growing FNH.

Conclusion

This study confirms that FNH may grow significantly without causing symptoms. A significant increase in size should not have any implications on clinical management if confident diagnosis by imaging has been established by a tertiary benign liver multidisciplinary team. Liver biopsy is only indicated in case of doubt after state-of-the-art imaging. Resection is deemed unnecessary if the diagnosis is confirmed by multiple imaging modalities in a tertiary referral centre.
Literature
1.
go back to reference Vilgrain V, Uzan F, Brancatelli G et al (2003) Prevalence of hepatic hemangioma in patients with focal nodular hyperplasia: MR imaging analysis. Radiology 229:75–79CrossRefPubMed Vilgrain V, Uzan F, Brancatelli G et al (2003) Prevalence of hepatic hemangioma in patients with focal nodular hyperplasia: MR imaging analysis. Radiology 229:75–79CrossRefPubMed
2.
go back to reference Luciani A, Kobeiter H, Maison P et al (2002) Focal nodular hyperplasia of the liver in men: is presentation the same in men and women? Gut 50:877–880CrossRefPubMedPubMedCentral Luciani A, Kobeiter H, Maison P et al (2002) Focal nodular hyperplasia of the liver in men: is presentation the same in men and women? Gut 50:877–880CrossRefPubMedPubMedCentral
3.
go back to reference Scalori A, Tavani A, Gallus S et al (2002) Oral contraceptives and the risk of focal nodular hyperplasia of the liver: a case-control study. Am J Obstet Gynecol 186:195–197CrossRefPubMed Scalori A, Tavani A, Gallus S et al (2002) Oral contraceptives and the risk of focal nodular hyperplasia of the liver: a case-control study. Am J Obstet Gynecol 186:195–197CrossRefPubMed
4.
go back to reference Mathieu D, Kobeiter H, Cherqui D et al (1998) Oral contraceptive intake in women with focal nodular hyperplasia of the liver. Lancet 352:1679–1680CrossRefPubMed Mathieu D, Kobeiter H, Cherqui D et al (1998) Oral contraceptive intake in women with focal nodular hyperplasia of the liver. Lancet 352:1679–1680CrossRefPubMed
5.
go back to reference Mathieu D, Vilgrain V, Mahfouz AE et al (1997) Benign liver tumors. Magn Reson Imaging Clin N Am 5:255–288PubMed Mathieu D, Vilgrain V, Mahfouz AE et al (1997) Benign liver tumors. Magn Reson Imaging Clin N Am 5:255–288PubMed
6.
go back to reference Terkivatan T, de Wilt JH, de Man RA et al (2001) Indications and long-term outcome of treatment for benign hepatic tumors: a critical appraisal. Arch Surg 136:1033–1038CrossRefPubMed Terkivatan T, de Wilt JH, de Man RA et al (2001) Indications and long-term outcome of treatment for benign hepatic tumors: a critical appraisal. Arch Surg 136:1033–1038CrossRefPubMed
7.
go back to reference Soussan M, Aube C, Bahrami S et al (2010) Incidental focal solid liver lesions: diagnostic performance of contrast-enhanced ultrasound and MR imaging. Eur Radiol 20:1715–1725CrossRefPubMed Soussan M, Aube C, Bahrami S et al (2010) Incidental focal solid liver lesions: diagnostic performance of contrast-enhanced ultrasound and MR imaging. Eur Radiol 20:1715–1725CrossRefPubMed
9.
go back to reference Behrend M, Flemming P, Halbfass HJ (2001) [Spontaneous bleeding of focal nodular hyperplasia as a rare cause of acute abdomen] Eine spontan blutende focal nodulare Hyperplasie als seltene Ursache eines akuten Abdomens. Chirurg 72:1201–1204CrossRefPubMed Behrend M, Flemming P, Halbfass HJ (2001) [Spontaneous bleeding of focal nodular hyperplasia as a rare cause of acute abdomen] Eine spontan blutende focal nodulare Hyperplasie als seltene Ursache eines akuten Abdomens. Chirurg 72:1201–1204CrossRefPubMed
10.
go back to reference Nguyen BN, Flejou JF, Terris B et al (1999) Focal nodular hyperplasia of the liver: a comprehensive pathologic study of 305 lesions and recognition of new histologic forms. Am J Surg Pathol 23:1441–1454CrossRefPubMed Nguyen BN, Flejou JF, Terris B et al (1999) Focal nodular hyperplasia of the liver: a comprehensive pathologic study of 305 lesions and recognition of new histologic forms. Am J Surg Pathol 23:1441–1454CrossRefPubMed
11.
go back to reference Rebouissou S, Bioulac-Sage P, Zucman-Rossi J (2008) Molecular pathogenesis of focal nodular hyperplasia and hepatocellular adenoma. J Hepatol 48:163–170CrossRefPubMed Rebouissou S, Bioulac-Sage P, Zucman-Rossi J (2008) Molecular pathogenesis of focal nodular hyperplasia and hepatocellular adenoma. J Hepatol 48:163–170CrossRefPubMed
12.
go back to reference Halankar JA, Kim TK, Jang HJ et al (2012) Understanding the natural history of focal nodular hyperplasia in the liver with MRI. Indian J Radiol Imaging 22:116–120CrossRefPubMedPubMedCentral Halankar JA, Kim TK, Jang HJ et al (2012) Understanding the natural history of focal nodular hyperplasia in the liver with MRI. Indian J Radiol Imaging 22:116–120CrossRefPubMedPubMedCentral
13.
go back to reference Hsee LC, McCall JL (2005) Koea JB Focal nodular hyperplasia: what are the indications for resection? HPB (Oxford) 7:298–302CrossRef Hsee LC, McCall JL (2005) Koea JB Focal nodular hyperplasia: what are the indications for resection? HPB (Oxford) 7:298–302CrossRef
14.
go back to reference Perrakis A, Demir R, Muller V et al (2012) Management of the focal nodular hyperplasia of the liver: evaluation of the surgical treatment comparing with observation only. Am J Surg 204:689–696CrossRefPubMed Perrakis A, Demir R, Muller V et al (2012) Management of the focal nodular hyperplasia of the liver: evaluation of the surgical treatment comparing with observation only. Am J Surg 204:689–696CrossRefPubMed
16.
go back to reference Eisenhauer EA, Therasse P, Bogaerts J et al (2009) New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 45:228–247CrossRefPubMed Eisenhauer EA, Therasse P, Bogaerts J et al (2009) New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 45:228–247CrossRefPubMed
18.
go back to reference Bioulac-Sage P, Laumonier H, Rullier A et al (2009) Over-expression of glutamine synthetase in focal nodular hyperplasia: a novel easy diagnostic tool in surgical pathology. Liver Int 29:459–465CrossRefPubMed Bioulac-Sage P, Laumonier H, Rullier A et al (2009) Over-expression of glutamine synthetase in focal nodular hyperplasia: a novel easy diagnostic tool in surgical pathology. Liver Int 29:459–465CrossRefPubMed
19.
go back to reference Grazioli L, Bondioni MP, Haradome H et al (2012) Hepatocellular adenoma and focal nodular hyperplasia: value of gadoxetic acid-enhanced MR imaging in differential diagnosis. Radiology 262:520–529CrossRefPubMed Grazioli L, Bondioni MP, Haradome H et al (2012) Hepatocellular adenoma and focal nodular hyperplasia: value of gadoxetic acid-enhanced MR imaging in differential diagnosis. Radiology 262:520–529CrossRefPubMed
20.
go back to reference Hussain SM, Terkivatan T, Zondervan PE et al (2004) Focal nodular hyperplasia: findings at state-of-the-art MR imaging, US, CT, and pathologic analysis. Radiographics 24:3–17 (discussion 18–19) CrossRefPubMed Hussain SM, Terkivatan T, Zondervan PE et al (2004) Focal nodular hyperplasia: findings at state-of-the-art MR imaging, US, CT, and pathologic analysis. Radiographics 24:3–17 (discussion 18–19) CrossRefPubMed
21.
go back to reference Piscaglia F, Lencioni R, Sagrini E et al (2010) Characterization of focal liver lesions with contrast-enhanced ultrasound. Ultrasound Med Biol 36:531–550CrossRefPubMed Piscaglia F, Lencioni R, Sagrini E et al (2010) Characterization of focal liver lesions with contrast-enhanced ultrasound. Ultrasound Med Biol 36:531–550CrossRefPubMed
22.
go back to reference Grazioli L, Morana G, Kirchin MA et al (2005) Accurate differentiation of focal nodular hyperplasia from hepatic adenoma at gadobenate dimeglumine-enhanced MR imaging: prospective study. Radiology 236:166–177CrossRefPubMed Grazioli L, Morana G, Kirchin MA et al (2005) Accurate differentiation of focal nodular hyperplasia from hepatic adenoma at gadobenate dimeglumine-enhanced MR imaging: prospective study. Radiology 236:166–177CrossRefPubMed
23.
go back to reference Grieser C, Steffen IG, Kramme IB et al (2014) Gadoxetic acid enhanced MRI for differentiation of FNH and HCA: a single centre experience. Eur Radiol 24:1339–1348CrossRefPubMed Grieser C, Steffen IG, Kramme IB et al (2014) Gadoxetic acid enhanced MRI for differentiation of FNH and HCA: a single centre experience. Eur Radiol 24:1339–1348CrossRefPubMed
24.
go back to reference Grieser C, Steffen IG, Seehofer D et al (2013) Histopathologically confirmed focal nodular hyperplasia of the liver: gadoxetic acid-enhanced MRI characteristics. Magn Reson Imaging 31:755–760CrossRefPubMed Grieser C, Steffen IG, Seehofer D et al (2013) Histopathologically confirmed focal nodular hyperplasia of the liver: gadoxetic acid-enhanced MRI characteristics. Magn Reson Imaging 31:755–760CrossRefPubMed
25.
go back to reference van Aalten SM, Witjes CD, de Man RA et al (2012) Can a decision-making model be justified in the management of hepatocellular adenoma? Liver Int 32:28–37CrossRefPubMed van Aalten SM, Witjes CD, de Man RA et al (2012) Can a decision-making model be justified in the management of hepatocellular adenoma? Liver Int 32:28–37CrossRefPubMed
26.
go back to reference Bonney GK, Gomez D, Al-Mukhtar A et al (2007) Indication for treatment and long-term outcome of focal nodular hyperplasia. HPB (Oxford) 9:368–372CrossRef Bonney GK, Gomez D, Al-Mukhtar A et al (2007) Indication for treatment and long-term outcome of focal nodular hyperplasia. HPB (Oxford) 9:368–372CrossRef
27.
go back to reference Cherqui D, Rahmouni A, Charlotte F et al (1995) Management of focal nodular hyperplasia and hepatocellular adenoma in young women: a series of 41 patients with clinical, radiological, and pathological correlations. Hepatology 22:1674–1681CrossRefPubMed Cherqui D, Rahmouni A, Charlotte F et al (1995) Management of focal nodular hyperplasia and hepatocellular adenoma in young women: a series of 41 patients with clinical, radiological, and pathological correlations. Hepatology 22:1674–1681CrossRefPubMed
28.
go back to reference de Wilt JH, de Man RA, Lameris JS et al (1996) [Focal nodular hyperplasia of the liver: assessment of diagnosis and treatment in 31 patients in 15 years] Focale nodulaire hyperplasie van de lever: evaluatie van diagnostiek en behandeling bij 31 patienten in 15 jaar. Ned Tijdschr Geneeskd 140:18–22PubMed de Wilt JH, de Man RA, Lameris JS et al (1996) [Focal nodular hyperplasia of the liver: assessment of diagnosis and treatment in 31 patients in 15 years] Focale nodulaire hyperplasie van de lever: evaluatie van diagnostiek en behandeling bij 31 patienten in 15 jaar. Ned Tijdschr Geneeskd 140:18–22PubMed
Metadata
Title
Growth of Focal Nodular Hyperplasia is Not a Reason for Surgical Intervention, but Patients Should be Referred to a Tertiary Referral Centre
Authors
Mirelle E. E. Bröker
Anne J. Klompenhouwer
Marcia P. Gaspersz
Annick M. E. Alleleyn
Roy S. Dwarkasing
Indra C. Pieters
Robert A. de Man
Jan N. M. IJzermans
Publication date
01-05-2018
Publisher
Springer International Publishing
Published in
World Journal of Surgery / Issue 5/2018
Print ISSN: 0364-2313
Electronic ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-017-4335-6

Other articles of this Issue 5/2018

World Journal of Surgery 5/2018 Go to the issue